Stoke Therapeutics Stock (NASDAQ: STOK) stock price, news, charts, stock research, profile.
You can purchase shares of Stoke Therapeutics (NASDAQ:STOK) through any online brokerage.
Other companies in Stoke Therapeutics’s space includes: KalVista Pharma (NASDAQ:KALV), Humacyte (NASDAQ:HUMA), Celcuity (NASDAQ:CELC), Upstream Bio (NASDAQ:UPB) and Altimmune (NASDAQ:ALT).
Stoke Therapeutics has a consensus price target of $22.25.
The stock price for Stoke Therapeutics (NASDAQ: STOK) is $8.4 last updated February 21, 2025 at 5:44 PM EST.
There are no upcoming dividends for Stoke Therapeutics.
Stoke Therapeutics’s Q1 earnings are confirmed for Monday, May 5, 2025.
There is no upcoming split for Stoke Therapeutics.
Stoke Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.